Ropes & Gray, Latham Steer $3.8B Eli Lilly Mental Health Deal
Eli Lilly said Thursday it will acquire New York-based drug developer AtaiBeckley Inc. in a deal valued at up to $3.8 billion, expanding its pipeline of experimental treatments for depression and...To view the full article, register now.
Already a subscriber? Click here to view full article